Drug Shortage Report for NIDAGEL
| Report ID | 183891 |
| Drug Identification Number | 02125226 |
| Brand name | NIDAGEL |
| Common or Proper name | NIDAGEL |
| Company Name | BAUSCH HEALTH, CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | METRONIDAZOLE |
| Strength(s) | 0.75% |
| Dosage form(s) | GEL |
| Route of administration | VAGINAL VAGINAL |
| Packaging size | 70g |
| ATC code | G01AF |
| ATC description | ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST. |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | 2023-03-31 |
| Actual start date | 2023-03-20 |
| Estimated end date | 2023-06-30 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-03-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-03-23 | French | Compare |
| v5 | 2023-03-23 | English | Compare |
| v4 | 2023-03-03 | French | Compare |
| v3 | 2023-03-03 | English | Compare |
| v2 | 2023-02-08 | French | Compare |
| v1 | 2023-02-08 | English | Compare |
Showing 1 to 6 of 6